S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
NASDAQ:SOPH

SOPHiA GENETICS (SOPH) Stock Price, News & Analysis

$4.93
-0.33 (-6.27%)
(As of 03/28/2024 ET)
Today's Range
$4.93
$5.21
50-Day Range
$4.21
$5.62
52-Week Range
$2.13
$7.37
Volume
21,152 shs
Average Volume
75,887 shs
Market Capitalization
$321.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

SOPHiA GENETICS MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
62.3% Upside
$8.00 Price Target
Short Interest
Healthy
0.09% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.42mentions of SOPHiA GENETICS in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.06) to ($0.91) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.49 out of 5 stars

Medical Sector

469th out of 939 stocks

Biological Products, Except Diagnostic Industry

77th out of 158 stocks

SOPH stock logo

About SOPHiA GENETICS Stock (NASDAQ:SOPH)

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

SOPH Stock Price History

SOPH Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Q4 2023 Sophia Genetics SA Earnings Call
Preview: Sophia Genetics's Earnings
See More Headlines
Receive SOPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/29/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:SOPH
Fax
N/A
Employees
430
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+62.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-78,980,000.00
Net Margins
-126.63%
Pretax Margin
-125.85%

Debt

Sales & Book Value

Annual Sales
$62.37 million
Book Value
$3.16 per share

Miscellaneous

Free Float
62,048,000
Market Cap
$321.58 million
Optionable
Not Optionable
Beta
1.18
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Jurgi Camblong M.B.A. (Age 45)
    Ph.D., Co-Founder, CEO & Director
    Comp: $1.1M
  • Mr. Ross Jordan Muken B.Sc. (Age 43)
    Executive VP, CFO & COO
  • Mr. Abhimanyu Verma
    Senior VP & CTO
  • Dr. Zhenyu Xu Ph.D. (Age 41)
    Executive VP & Chief Scientific Officer
  • Katherine Bailon
    Vice President of Investor Relations
  • Mr. Daan van Well L.L.M. (Age 49)
    M.B.A., Executive VP, Chief Legal & Compliance Officer
  • Ms. Manuela Da Silva Valente B.A. (Age 53)
    Senior VP & Chief People Officer
  • Mr. Kevin Puylaert
    VP & MD of EMEA
  • Dr. Philippe Menu M.B.A. (Age 42)
    M.D., Ph.D., Executive VP, Chief Medical Officer & Chief Product Officer
  • Mr. Peter Casasanto
    Senior VP & Chief BioPharma Officer

SOPH Stock Analysis - Frequently Asked Questions

Should I buy or sell SOPHiA GENETICS stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SOPHiA GENETICS in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SOPH shares.
View SOPH analyst ratings
or view top-rated stocks.

What is SOPHiA GENETICS's stock price target for 2024?

2 brokers have issued 12-month target prices for SOPHiA GENETICS's stock. Their SOPH share price targets range from $8.00 to $8.00. On average, they expect the company's share price to reach $8.00 in the next year. This suggests a possible upside of 62.3% from the stock's current price.
View analysts price targets for SOPH
or view top-rated stocks among Wall Street analysts.

How have SOPH shares performed in 2024?

SOPHiA GENETICS's stock was trading at $4.71 at the start of the year. Since then, SOPH shares have increased by 4.7% and is now trading at $4.93.
View the best growth stocks for 2024 here
.

Are investors shorting SOPHiA GENETICS?

SOPHiA GENETICS saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 43,000 shares, a decrease of 28.6% from the February 29th total of 60,200 shares. Based on an average trading volume of 48,100 shares, the short-interest ratio is currently 0.9 days. Currently, 0.1% of the shares of the company are short sold.
View SOPHiA GENETICS's Short Interest
.

When is SOPHiA GENETICS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our SOPH earnings forecast
.

How were SOPHiA GENETICS's earnings last quarter?

SOPHiA GENETICS SA (NASDAQ:SOPH) released its quarterly earnings results on Tuesday, March, 5th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.25) by $0.12. The business had revenue of $17.05 million for the quarter, compared to analysts' expectations of $16.78 million. SOPHiA GENETICS had a negative net margin of 126.63% and a negative trailing twelve-month return on equity of 47.40%. During the same quarter last year, the business posted ($0.22) earnings per share.

What guidance has SOPHiA GENETICS issued on next quarter's earnings?

SOPHiA GENETICS issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $78.0 million-$81.0 million, compared to the consensus revenue estimate of $82.1 million.

When did SOPHiA GENETICS IPO?

SOPHiA GENETICS (SOPH) raised $234 million in an initial public offering (IPO) on Friday, July 23rd 2021. The company issued 13,000,000 shares at a price of $17.00-$19.00 per share.

Who are SOPHiA GENETICS's major shareholders?

SOPHiA GENETICS's stock is owned by many different retail and institutional investors. Top institutional shareholders include Principal Financial Group Inc. (0.00%), Parkman Healthcare Partners LLC (0.32%), Essex Investment Management Co. LLC (0.00%), Federated Hermes Inc. (0.00%), Legato Capital Management LLC (0.00%) and Zurcher Kantonalbank Zurich Cantonalbank (0.00%).

How do I buy shares of SOPHiA GENETICS?

Shares of SOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SOPH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners